| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |